Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-muta
A phase 3 trial of Zoldonrasib, CAPOX, FLOT in pancreatic ductal adenocarcinoma, run by Revolution Medicines, Inc., now recruiting.
Overview
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) is a phase 3 interventional study registered as NCT07621718 by Revolution Medicines, Inc., with 670 participants planned, started 2026-05-22 and due to reach its primary completion in 2028-12-30. Interventions recorded: Zoldonrasib, Placebo, Oxaliplatin, Leucovorin (Calcium Folinate), 5-Fluorouracil. Conditions listed: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialStudy of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mut
Shares Zoldonrasib, Revolution Medicines, Gemcitabine, Pancreatic ductal adenocarcinoma.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares Leucovorin (folinic acid), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin).
- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin).
- TrialAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Gemcitabine, Pancreatic ductal adenocarcinoma.
- TrialStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Shares Zoldonrasib, Revolution Medicines, Gemcitabine, Pancreatic ductal adenocarcinoma.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin).
- TrialA Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin).
- TrialStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Shares Revolution Medicines, Gemcitabine, Pancreatic ductal adenocarcinoma.